cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

<table><tr><td><table class="algorithm" id="figbox1"><tr><td colspan="2">The general AIMS of cNEUPRO are:</td></tr><tr><td colspan="2">(i) Detection of new biomarkers for the early, predictive and differential diagnosis of neurodegenerative</td></tr><tr><td colspan="2">   diseases in CSF and blood</td></tr><tr><td colspan="2">(ii) Development of new diagnostic assays for the early and predictive diagnosis of neurodegenerative</td></tr><tr><td colspan="2">    diseases in CSF and blood</td></tr><tr><td colspan="2">(iii) Contribution to the standardization of neurochemical dementia diagnosis</td></tr><tr><td colspan="2">(iv) Establishment of two neurochemical dementia diagnosis reference-centers in Hungary and Portugal</td></tr></table></td></tr></table>

International Journal of Alzheimer’s Disease

figbox1

Box 1

Box 1: cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases 